InsidersTradesSigma
Follow the 蔚蓝生物 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 蔚蓝生物 has recorded 6 insider filings. Market capitalisation: €2.8bn. The latest transaction was reported on 28 March 2025 (Sale). Among the most active insiders: 贾德强. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
蔚蓝生物是一家在XSHG市场上市的健康和制药领域的公司。它专注于开发创新解决方案以增进人类健康。